Oncogene's Shares Rise After
Drug-Discovery Patent Issued

Dow Jones Newswires

Updated Sept. 9, 1997 4:20 pm ET

UNIONDALE, N.Y. -- Shares of Oncogene Science Inc. rose 16.5% Tuesday after the company was issued a U.S. patent that broadly claims the use of so-called reporter genes to identify chemical compounds that modulate gene transcription inside the body.

In late afternoon trading on the Nasdaq Stock Market, the Uniondale, N.Y., company's shares were up $2.72 cents, or 32.3%, to $11.25.